Clinical Trial Update: BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia [Phase 3]

View source ↗

Summary

Bayer's BAY12-8039 completed a Phase 3 trial for conditions including aspiration pneumonia, pneumonia, and lung abscess.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspiration Pneumonia
• Lung Abscess
• Pneumonia

Drugs mentioned

• BAY12-8039

Snippet

Sponsor: Bayer | Conditions: Pneumonia, Aspiration, Lung Abscess | Phase 3 | Status: COMPLETED